# New Equilibrium Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/new-equilibrium-biosciences

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.newequilibriumbio.com
- Total disclosed funding: $10M
- Latest round: Seed (Mar 31, 2021)
- Investors on record: 2

## About

Founded in 2019 and based in Massachusetts, US, New Equilibrium Biosciences operates as a drug discovery company for intrinsically disordered proteins. The firm was founded by Dr. Virginia Burger and Dr. Peter Tompa and has raised a seed funding of USD 10 million in March 2021.

New Equilibrium Biosciences discover new medicines for patients with life-threatening diseases including rational drug design against intrinsically disordered proteins (IDPs).

New Equilibrium Biosciences plans to use its seed funding to scale up its R&D facility, expand the team, and accelerate programs targeting IDPs while exploring strategic partnerships.

## Funding rounds

- Seed, Mar 31, 2021, $10M — RA Capital Management, Petri

## Investors

- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Seed
- Petri (https://capitalatlas.ai/funds/petri) — Seed